| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.25B | +15.2% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥-0.03B | — |
| Net income | ¥-0.03B | — |
| Gross margin | 20.9% | Net margin -11.4% |
| Revenue Q/Q | -7.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.20B | 79.1% |
| R&D | ¥0.02B | 9.5% |
| SG&A | ¥0.03B | 11.9% |
| Tax & other | ¥0.00B | 1.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
*ST益通 ・ 富临精工 ・ 金石亚药 ・ 中泰股份 ・ 广生堂 ・ 清水源 ・ 鹏辉能源 ・ 美康生物 ・ 运达科技 ・ 鲍斯股份 ・ 金雷股份 ・ 双杰电气
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies